Pirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.11, 2005-11, pp. : 1443-1447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite

Pirfenidone: a guide to its use in idiopathic pulmonary fibrosis

By Keating Gillian M. Lyseng-Williamson Katherine A. Carter Natalie J.

Drugs & Therapy Perspectives, Vol. 28, Iss. 7, 2012-07 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Recognition and Treatment of Idiopathic Pulmonary Fibrosis

By Nicod L.P.

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 555-562

Adis International

Access to resources Recommend Favorite

Idiopathic Pulmonary Fibrosis: Pathogenesis and Therapeutic Approaches

By Selman M.

Drugs, Vol. 64, Iss. 4, 2004-01 ,pp. : 405-430

Adis International

Access to resources Recommend Favorite

Apoptosis Induction by Thalidomide: Critical for Limb Teratogenicity but Therapeutic Potential in Idiopathic Pulmonary Fibrosis?

Current Molecular Pharmacology, Vol. 4, Iss. 1, 2011-01 ,pp. : 26-61

Bentham Science Publishers

Access to resources Recommend Favorite